Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
Statistics in Medicine · 2025
DOI: 10.1002/sim.70202 ↗At a glance
Übersichtsarbeit in Statistics in Medicine, 2025. Written by David S Robertson and 6 co-authors. Institution: MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. Major MEDLINE topics: Research Design, Adaptive Clinical Trials as Topic. 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council, HCRW_, Cancer Research UK.
Abstract (original language)
In adaptive clinical trials, the conventional confidence interval (CI) for a treatment effect is prone to undesirable properties such as undercoverage and potential inconsistency with the final hypothesis testing decision. Accordingly, as is stated in recent regulatory guidance on adaptive designs, there is the need for caution in the interpretation of CIs constructed during and after an adaptive clinical trial. However, it may be unclear which of the available CIs in the literature are preferable. This paper is the second in a two‐part series that explores CIs for adaptive trials. Part I provided a methodological review of approaches to construct CIs for adaptive designs. In this paper (Part II), we present an extended case study based around a two‐stage group sequential trial, including a comprehensive simulation study of the proposed CIs for this setting. This facilitates an expanded description of considerations around what makes for an effective CI procedure following an adaptive trial. We show that the CIs can have notably different properties. Finally, we propose a set of guidelines for researchers around the choice of CIs and the reporting of CIs following an adaptive design.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
- University of Bath, Bath, UK.
- MRC Clinical Trials Unit at UCL, London, UK.
- Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, UK.
- Statistics and Decision Sciences, Janssen R&D, High Wycombe, UK.
- Centre for Trials Research, Cardiff University, Cardiff, UK.
ORCID profiles: David S Robertson, Thomas Burnett, Babak Choodari-Oskooei
Funding
- Medical Research Council
- HCRW_
- Cancer Research UK
- Health and Care Research Wales
Cite
APA
Robertson, D. S., Burnett, T., Choodari-Oskooei, B., Dimairo, M., Grayling, M., Pallmann, P., & Jaki, T. (2025). Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance. Statistics in Medicine. https://doi.org/10.1002/sim.70202
Vancouver
Robertson DS, Burnett T, Choodari-Oskooei B, Dimairo M, Grayling M, Pallmann P, et al. Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance. Statistics in Medicine. 2025. doi:10.1002/sim.70202
BibTeX
@article{Robertson2025,
author = {Robertson, David S and Burnett, Thomas and Choodari-Oskooei, Babak and Dimairo, Munya and Grayling, Michael and Pallmann, Philip and Jaki, Thomas},
title = {Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70202}
}
EUVIMED